Pathos AI

Chicago, IL · Founded 2020 · Privately Held (backing)

Developer of a drug discovery platform designed to reduce the duration of the medication development process. Pathos AI is based in Chicago, IL and was founded in 2020. It was valued at $1.6 billion at its later-stage round in May 2025, the last priced event on record. It has raised $467 million across 3 recorded rounds; the latest was a $283 million later-stage round in Apr 2025.

PMV mark · valuation
$1.6B
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$467.0M
Last round
Later Stage VC
Apr 2025

Who backs Pathos AI?

5 investors
InvestorType
New Enterprise AssociatesVenture capital
Builders VCVenture capital
Lightbank (Venture Capital)Venture capital
Eric Lefkofsky—
Revolution (Washington DC)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pathos AI investors

5 investors are on record for Pathos AI, including New Enterprise Associates, Builders VC, Lightbank (Venture Capital) and Eric Lefkofsky. The later-stage round in Apr 2025 drew 11 investors.

Free account
More of Pathos AI with a free account
  • ·Watch Pathos AI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Pathos AI. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View